Why most biological age tests fall short
The £299 saliva kit problem
Consumer telomere testing has become a significant industry. The premise is appealing — measure the caps on your chromosomes and get a biological age number. The problem is that the measurement method (quantitative PCR) has an intrinsic variability rate of approximately 20%. That means two samples from the same person, processed at different times, can produce readings that differ enough to change the clinical interpretation. You may be measuring sample storage conditions as much as your biology.
More fundamentally, a 2025 multi-cohort study published in Aging Cell directly compared telomere length against DNA methylation clocks across 4,500+ participants linked to the National Death Index. The finding was unambiguous: DNA methylation clocks — specifically GrimAge acceleration and DunedinPACE — significantly outperformed telomere length for predicting mortality. The telomeres measure something real. The methylation clocks measure something more predictive, more actionable, and more sensitive to intervention.
What consumer telomere tests don't tell you
The qPCR method has ~20% variability — two samples from the same person can produce clinically different readings
Telomere length varies substantially between tissues — the blood cells measured are not the cells most relevant to brain, cardiac, or metabolic ageing
Telomere length is a population-level association, not a reliable individual-level clinical measurement
It cannot tell you your pace of ageing — only a rough snapshot that may change based on when and how the sample was collected
It cannot identify what is driving accelerated ageing or what to do about it
The tests
Clinical-grade biological age investigation
Available through Detective Health via Nordic Labs UK, TruDiagnostic offers two complementary panels — one mapping your biological age through epigenetic analysis, one mapping the metabolic drivers of that ageing through comprehensive biomarker profiling.
Examines methylation patterns at approximately one million locations on your DNA to calculate biological age using multiple validated algorithms. Tells you not just how old your cells are, but how fast you are currently ageing — and your risk of age-related disease.
OMICm Biological Age — Harvard/Brigham and Women's Hospital algorithm examining ~1 million methylation sites
DunedinPACE — pace of ageing clock (how fast you're ageing right now, sensitive to intervention)
Immunosenescence ratios — immune ageing and chronic inflammation indices
Epigenetic risks for Type 2 Diabetes and systemic inflammation
Telomere length — included as one marker among many, in proper context
Mitotic Clock — stem cell division evaluation
OMICm FitAge — fitness age linked to epigenetic biomarkers
SYMPHONYAge — organ-specific biological age estimates
Epigenetic risk of smoking and alcohol-related diseases
Epigenetic response to weight-loss strategies
Risk of age-related complications if biological age increases or decreases by 1–5 years
Blood draw required
Results in 4–6 weeks
Comprehensive metabolomic profiling across interconnected biological pathways. Identifies the specific nutritional, inflammatory, toxic, and metabolic drivers of biological ageing — and what to do about them.
Essential micronutrients — vitamins, minerals, cofactors at functional levels
Antioxidant compounds — glutathione, CoQ10, and antioxidant capacity
Omega fatty acid profile — EPA, DHA, AA, omega-6:3 ratio
Amino acid profiles — essential and conditionally essential amino acids
Environmental toxicants — heavy metals and persistent organic pollutants
Inflammatory markers — systemic and metabolic inflammation indicators
Oxidative stress parameters — markers of cellular oxidative damage
Neurocognitive indicators — metabolites relevant to brain health and function
Metabolic efficiency markers — mitochondrial and energy metabolism
Immune competence markers — immune system functional status
Blood draw required
Results in 4–6 weeks
What's included
TruAge Complete Collection — biological age, DunedinPACE, OMICm Age, epigenetic disease risk, immunosenescence, organ-specific ageing
TruHealth — 110+ metabolomic biomarkers covering micronutrients, antioxidants, fatty acids, toxicants, inflammation, and oxidative stress
Written clinical interpretation report — findings in plain language with specific intervention priorities ranked by clinical significance
Follow-up consultation — 45 minutes with Stephen to discuss findings, answer questions, and agree a targeted protocol
What you'll know afterwards
Your actual biological age versus chronological age
Your current pace of ageing — whether you're ageing faster or slower than your peers
The specific nutritional, inflammatory, toxic, and metabolic factors driving your biological age
Your epigenetic disease risk and how it changes with biological age
A specific, prioritised intervention plan addressing what's actually driving your ageing
A baseline for retesting at 12 months to measure whether the pace has changed
The science behind the clocks
Why DNA methylation outperforms telomere length
DNA methylation clocks work by examining the pattern of methyl groups attached to specific locations on the genome — a pattern that changes predictably with biological ageing and with the environmental and lifestyle factors that accelerate or decelerate it. Unlike telomere length, methylation patterns are tissue-consistent, highly reproducible, and directly associated with mortality risk in large population studies.
The Clocks — What Each Measures
OMICm Age
Developed in partnership with scientists from Brigham and Women's Hospital, Harvard Medical School. Calculates biological age by examining age-associated methylation patterns at approximately one million locations on the patient's DNA. The most comprehensive epigenetic age algorithm currently available clinically.
DunedinPACE
Measures the pace of ageing — how fast you are currently ageing — rather than age at a single point. Developed from a longitudinal study tracking the same individuals from birth to midlife. Critically, DunedinPACE is sensitive to intervention over 6–12 months, making it the most useful clock for measuring whether lifestyle and nutritional changes are actually working. A 2025 multi-cohort study confirmed DunedinPACE as among the strongest predictors of mortality (C statistic 0.75) — significantly outperforming telomere length.
SYMPHONYAge
Organ-specific biological age estimates — providing separate biological age calculations for different organ systems (brain, heart, lung, kidney, liver, immune system, metabolic). Identifies which systems are ageing fastest and therefore where intervention priority lies.
Immunosenescence
Epigenetic markers of immune system ageing — immune senescence is both a driver and a consequence of accelerated biological ageing. Elevated immunosenescence is associated with increased infection susceptibility, reduced vaccine response, and higher cancer risk.
Mitotic Clock
Tracks the cumulative number of stem cell divisions — a separate ageing signal from methylation clocks that reflects cellular turnover rate and is particularly relevant to cancer risk assessment.
How it works
From booking to protocol
1
Discovery call
30-minute call with Stephen to discuss your health picture, your goals, and whether the Longevity Investigation is the right starting point or should be combined with the TDG Five-Test Programme for a more complete clinical picture.
2
Blood draw
TruAge and TruHealth both require a blood draw. Samples are processed via Nordic Labs UK and sent to TruDiagnostic's laboratory. A local phlebotomy service can be arranged if needed. Results typically return within 4–6 weeks.
3
Clinical interpretation report
Stephen produces a written report translating your results into plain clinical language — what each finding means, how the pieces connect, and what the priority intervention areas are. Delivered before your follow-up consultation.
4
Follow-up consultation
45-minute consultation to discuss findings, answer questions, and build a specific protocol targeting the drivers of biological age acceleration identified in your results. Dietary, supplemental, and lifestyle interventions prioritised by clinical significance.
5
12-month retest
DunedinPACE is specifically designed to detect change over 6–12 months. Retesting at 12 months shows whether your pace of ageing has actually shifted in response to the protocol. This is the difference between assuming an intervention is working and measuring whether it is.
Is this for you?
Who benefits most from the Longevity Investigation
The DH Longevity Investigation is most valuable for people who are broadly well but want to understand how fast they're ageing and what's driving it — before symptoms or diagnoses make the question urgent. It is also valuable alongside the TDG Five-Test Programme for clients who want to understand not just what is currently dysfunctional but what the trajectory of that dysfunction means for long-term healthspan.
Specific indications include: strong family history of age-related disease (cardiovascular, neurodegenerative, cancer); concern about accelerated ageing following prolonged stress, significant illness, or toxic exposure; interest in quantifying the biological impact of lifestyle interventions; and anyone investing significantly in longevity who wants objective measurement rather than subjective tracking.
It is not a substitute for investigation of active symptoms. If you are currently experiencing multi-system symptoms that are unresolved, the TDG Five-Test Programme is the appropriate starting point. The Longevity Investigation and the TDG programme are complementary — they answer different questions about the same biology.
Frequently asked
Questions about the Longevity Investigation
How is this different from a consumer biological age test?
Consumer tests typically use qPCR telomere measurement — which has approximately 20% variability and has been shown in peer-reviewed studies to be less predictive of mortality than DNA methylation clocks. TruDiagnostic's analysis uses DNA methylation at approximately one million genomic locations, with algorithms developed in partnership with Harvard Medical School. The measurement is categorically more reliable and more predictive. The clinical interpretation layer — translating results into a specific intervention plan — is the other differentiator. A number without context is not useful clinically.
Why does the combined test cost less than buying separately?
TruAge + TruHealth separately total £820. The combined panel is available at £589 client price — a saving of £231 — because the two samples can be processed together. The DH Longevity Investigation packages the combined test with clinical interpretation and consultation at £750 total, which includes Stephen's report writing and follow-up time.
What does DunedinPACE actually measure?
DunedinPACE measures the pace of biological ageing — not your biological age at a single point, but how fast you are ageing right now. A score of 1.0 means you're ageing at the average rate. A score of 0.8 means you're ageing 20% slower than average. A score of 1.2 means you're ageing 20% faster. Crucially, DunedinPACE is sensitive to intervention — studies have shown measurable changes in response to diet, exercise, sleep, and stress management over 6–12 months. This makes it the most clinically useful clock for tracking whether what you're doing is actually working.
Can I do this alongside the TDG Five-Test Programme?
Yes, and in many cases this combination produces the most complete clinical picture available. The TDG programme maps current dysfunction — what is driving your symptoms now. The Longevity Investigation maps the biological age trajectory and the metabolic drivers of long-term healthspan. Together they answer both the immediate question (what's wrong?) and the longer-term question (how fast am I ageing and why?). A combined approach is worth discussing at discovery call stage.
How soon should I retest?
12 months is the recommended retesting interval for DunedinPACE — this gives enough time for meaningful biological change to occur and be detected by the methylation analysis. Testing too soon (under 6 months) may not capture genuine biological change. Testing at 12 months after a targeted protocol gives you an objective measure of whether the intervention has actually shifted your pace of ageing.
Start here
Ready to find out how fast you're actually ageing?
Book a discovery call and we'll establish whether the Longevity Investigation is the right starting point, or whether it should be combined with the TDG programme for a more complete picture.